Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

In its 2024 opinion in Vanegas v. Signet Builders, Inc., the U.S. Court of Appeals for the Seventh Circuit joined a growing number of federal ...

The Board also approved a Miss. State career center funded through the U.S. Department of Education Rehabilitation Services ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

Unusual total active option classes on open include: B2Gold ( BTG ), Verizon ( VZ ), Zscaler ( ZS ), American Express ( AXP ), Mastercard ( MA ), KE Holdings ( BEKE ), Novo Nordisk ( NVO ), Microchip ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

Rare disease drug maker Pharming Group is calling off the search for a CEO successor to longtime chief Sijmen de Vries after ...

Rising awareness, innovative therapies, and evolving treatment options drive this growth.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...